Green Cross Corporation
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 7/5/2022
Pipeline by Phase
Therapeutic Focus
Clinical Trials (45)
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Started: 10/1/2016
Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
Started: 4/30/2019
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older
Started: 10/10/2016
A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children
Started: 9/1/2015
An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Started: 6/1/2014
To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults
Started: 6/1/2013
A Multicenter, Double-blind, Parallel Phase III Study
Started: 10/1/2014
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
Started: 8/1/2013
To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults
Started: 5/1/2014
Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy
Started: 12/1/2012
Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
Started: 9/1/2011
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Started: 10/1/2009
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
Started: 10/1/2009
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Started: 7/5/2022
A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
Started: 7/14/2021
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
Started: 11/20/2019
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
Started: 10/1/2018
A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients
Started: 2/1/2015
To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children
Started: 8/1/2011
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
Started: 4/2/2018
A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
Started: 1/21/2019
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
Started: 11/20/2017
A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
Started: 11/9/2015
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
Started: 3/1/2015
Evaluate the Safety and Exploratory Efficacy of GC1119
Started: 11/1/2012
Safety Study of MG1102 in Patients With Solid Tumors
Started: 11/1/2010
A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers
Started: 8/1/2013
Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)
Started: 10/1/2014
Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers
Started: 2/1/2010
A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)
Started: 5/1/2014
Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection
Started: 8/1/2012
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
Started: 3/1/2012
To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
Started: 6/1/2011
To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
Started: 5/1/2010
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
Started: 2/1/2019
Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.
Started: 10/1/2010
To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis
Started: 5/1/2012
Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
Started: 1/1/2012